Your browser doesn't support javascript.
loading
Patients with BRCA mutations have superior outcomes after intraperitoneal chemotherapy in optimally resected high grade ovarian cancer.
Naumann, R Wendel; Morris, Jacob C; Tait, David L; Higgins, Robert V; Crane, Erin K; Drury, Lane K; Amacker-North, Lisa; Templin, Megan; Brown, Jubilee.
Afiliação
  • Naumann RW; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA. Electronic address: wnaumann@mac.com.
  • Morris JC; Dartmouth College, Hanover, NH, USA.
  • Tait DL; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Higgins RV; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Crane EK; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Drury LK; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Amacker-North L; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Templin M; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
  • Brown J; Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
Gynecol Oncol ; 151(3): 477-480, 2018 12.
Article em En | MEDLINE | ID: mdl-30309722

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Quimioterapia Adjuvante / Genes BRCA1 / Genes BRCA2 Limite: Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Quimioterapia Adjuvante / Genes BRCA1 / Genes BRCA2 Limite: Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Ano de publicação: 2018 Tipo de documento: Article
...